C 60 by Grebinyk, Anna et al.
TU Ilmenau | Universitätsbibliothek | ilmedia, 2019 
http://www.tu-ilmenau.de/ilmedia 
Grebinyk, Anna; Prylutska, Svitlana; Grynyuk, Iryna; Kolp, Benjamin; Hurmach, 
Vasyl; Sliva, Tetjana; Amirkhanov, Vladimir; Trush, Victor; Matyshevska, Olga; 
Slobodyanik, Mykola; Prylutskyy, Yuriy; Frohme, Marcus; Ritter, Uwe: 
C60 fullerene effects on diphenyl-N-(trichloroacetyl)-amidophosphate 
interaction with DNA in silico and its cytotoxic activity against human leukemic 
cell line in vitro 
Original published in: Nanoscale research letters : NRL. - New York, NY [u.a.] : Springer. - 
13 (2018), art. 81, 9 pp. 
Original published: 2018-03-09 
ISSN: 1556-276X 
DOI: 10.1186/s11671-018-2490-9 
[Visited: 2019-03-28] 
This work is licensed under a Creative Commons Attribution 4.0 
International license. To view a copy of this license, visit  
http://creativecommons.org/licenses/by/4.0/ 
NANO EXPRESS Open Access
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(trichloroacetyl)-amidophosphate
Interaction with DNA In Silico and Its
Cytotoxic Activity Against Human Leukemic
Cell Line In Vitro
A. Grebinyk1,2, S. Prylutska4*, I. Grynyuk4, B. Kolp2, V. Hurmach1, T. Sliva4, V. Amirkhanov4, V. Trush4, O. Matyshevska1,
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Abstract
New representative of carbacylamidophosphates - diphenyl-N-(trichloroacetyl)-amidophosphate (HL), which contains
two phenoxy substituents near the phosphoryl group, was synthesized, identified by elemental analysis and IR and
NMR spectroscopy, and tested as a cytotoxic agent itself and in combination with C60 fullerene.
According to molecular simulation results, C60 fullerene and HL could interact with DNA and form a rigid complex
stabilized by stacking interactions of HL phenyl groups with C60 fullerene and DNA G nucleotide, as well as
by interactions of HL CCl3 group by ion-π bonds with C60 molecule and by electrostatic bonds with DNA G nucleotide.
With the use of MTT test, the cytotoxic activity of HL against human leukemic CCRF-CM cells with IC50 value detected
at 10 μM concentration at 72 h of cells treatment was shown. Under combined action of 16 μM C60 fullerene and HL,
the value of IC50 was detected at lower 5 μM HL concentration and at earlier 48 h period of incubation, besides the
cytotoxic effect of HL was observed at a low 2.5 μM concentration at which HL by itself had no influence on cell viability.
Binding of C60 fullerene and HL with minor DNA groove with formation of a stable complex is assumed to be one of the
possible reasons of their synergistic inhibition of CCRF-CЕM cells proliferation.
Application of C60 fullerene in combination with 2.5 μM HL was shown to have no harmful effect on structural stability
of blood erythrocytes membrane. Thus, combined action of C60 fullerene and HL in a low concentration potentiated
HL cytotoxic effect against human leukemic cells and was not followed by hemolytic effect.
Keywords: Diphenyl-N-(trichloroacetyl)-amidophosphate (HL), C60 fullerene, Leukemic CCRF-CEM cells, DNA, Molecular
simulation
Background
The representative of carbon nanostructure C60 fullerene
is shown to possess unique physicochemical properties
and biological activity not only as antioxidant or photo-
sensitizator but also as modificator of anticancer drugs
toxic effect due to its ability to penetrate inside the cell
and to function as a drug carrier [1–4]. C60 molecule
can interact with chemotherapeutic drugs such as doxo-
rubicin, cisplatin, and paclitaxel and can form complexes
with them enhancing the therapeutic effect [5–8].
Carbacylamidophosphates (CAPh) are organic mole-
cules which have attracted attention due to its particular
structure, biological activity, and perspectives of biomed-
ical application [9–12]. The presence of peptide and
phosphoramide groups combined together in the frag-
ment C(O)N(H)P(O) of the molecule determines its inter-
action with biological molecules and cell membranes.
Variation of substituents near phosphoryl and carbonyl
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groups gives possibility to modulate CAPh stereochemical
and pharmacological properties. In particular, different
CAPh representatives were shown to possess antineoplas-
tic activity [13, 14].
Recently, we have confirmed that CAPh representative
dimethyl-N-(benzoyl)-amidophosphate used in millimolar
concentrations range decreased the viability of leukemic
L1210 cells and that its toxic effect was facilitated by C60
fullerene [15]. We have shown also that introduction of
additional aromatic substituents and electronegative CCl3
group into CAPh structure resulted in enhancement of its
toxicity [16]. Thus, significant toxic effect of dimorfolido-
N-trichloroacetylphosphoramide was shown against hu-
man leukemic cells of different origin, but its effective
concentration was still high and no enhancement of
toxicity after combined action with C60 fullerene was
observed. In continuation of these investigations, we
synthesized a new representative of CAPh diphenyl-N-
(trichloroacetyl)-amidophosphate (HL) which have two
phenoxy substituens instead of morfolido groups near
phosphoryl group (Fig. 1).
Тhe aim of the research was to estimate biological activ-
ity of diphenyl-N-(trichloroacetyl)-amidophosphate (HL)
alone or in combination with C60 fullerene with the use of
in silico analysis of their interaction with DNA and in
vitro study of cytotoxic effects against human leukemic
cell line.
Methods/Experimental
Chemicals
RPMI 1640 liquid medium, Fetal Bovine Serum (FBS),
Penicillin/Streptomycin and L-gluthamine (Biochrom,
Germany), Dimethylsulfoxide (DMSO) (Carl Roth GmbH
+Co, Germany), MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide] (Sigma-Aldrich Co, Ltd.,
USA), HCl (Kharkivreachim, Ukraine).
Characterization of Chemical Compound
To increase solubility, we have obtained sodium salt of
diphenyl-N-(trichloroacetyl)-amidophosphate (HL) accord-
ing to following reactions (Fig. 2).
The trichlorophosphazothrichloroacetyl solution
(0.035 M) in 200 ml of chloroform was slowly added to
a well-stirred sodium phenolate suspension (0.106 M,
12.3 g) in 150 ml of chloroform (Fig. 2; stage 1). The
mixture temperature was not allowed to rise above
40–50 °C. Stirring was continued for about 1 h, and
then the solution was heated up to 70 °C and stirred for
20 min at these conditions. The resulting product
triphenoxyphosphazothrichloroacetyl was evaporated.
Then, 40 ml of 1 M NaOH was added and refluxed for
90 min (Fig. 2; stage 2). A resulting mixture was evapo-
rated. The solid precipitate of sodium HL was washed
three times of diethyl ether and recrystallized from
i-propanole as a white crystalline powder (80% yield).
Colorless crystals of NaL·3H2O suitable for X-ray ana-
lysis were obtained by i-PrOH:H2O (9:1 v/v) solution
slow evaporation. The compound is air-stable, highly
soluble in water and alcohols. M.p. 215 °С.
HL was identified by elemental analysis and IR and
NMR spectroscopy: elemental analyses (C, H, N) were
performed using the EL III Universal CHNOS elemen-
tal analyzer. IR spectral measurements were performed
for samples as KBr pellets on a Perkin–Elmer Spectrum
BX FT-IR spectrometer with resolution of 2 cm− 1 and
accumulations of 8 scans, which are combined to aver-
age out random absorption artifactsin the spectral
range 4000–400 cm− 1. 1H NMR spectra in DMSO-d6
solutions were recorded on an AVANCE 400Bruker
NMR spectrometer at room temperature.
HL: IR (cm−1): 1639 vs, sh (νCO); 1353 s, sh (Amide
II); 1194 s, sh (νPO); 941 s, sh (νPN).
1H NMR (DMSO-d6): 7.05 (t, 2H, γ-CH2); 7.205, 7.255
(dt, 8H, α- and β-CH2).
For CCl3C(O)N(Na)P(O)(OC6H5)2 the elemental com-
position was determined, %: C 40.58, H 2.35, N 3.15;
and calculated, %: C 40.37, H 2.42, N 3.36.
Synthesis and Characterization of C60 Fullerene
A highly stable aqueous colloid solution of C60 fullerene
(200 μM, purity > 99.5%, nanoparticle average size up to
50 nm) was synthesized in Technical University of Ilme-
nau (Germany) as described in [17, 18].
Сell Culture
The experiments were done on human acute T-cell
leukemic CCRF-CM cell line. Cell line was purchased
from the Leibniz Institute DSMZ-German Collection of
Microorganisms and Cell Cultures: CCRF-CM (ACC
240). Cells were cultured in RPMI 1640 medium supple-
mented with 10% FBS, 1% Penicillin/Streptomycin, and
Fig. 1 The structure of diphenyl-N-(trichloroacetyl)-amidophosphate (HL)
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2 mM Gluthamine, using 25 cm2 flasks at a 37 °C with
5% CO2 in humidified incubator.
Cells in RPMI 1640 medium were incubated with C60
fullerene (16 μM) or HL (2.5, 5, and 10 μM) separately
and together during 24, 48, and 72 h. Cell survival with-
out the addition of HL or C60 fullerene was received as
100% (control sample contained 0.05 M DMSO).
Cell Viability (MTT) Assay
Cell viability was assessed by the MTT [3-(4,5-
dimethylthiazol-2- yl)-2,5-diphenyl tetrazolium bromide]
reduction assay [19]. At indicated time points of incuba-
tion, 100 μl aliquots (0,5 × 104 cells) were placed into the
96-well microplates Sarstedt (Nümbrecht, Germany),
10 μl of MTT solution (5 mg/ml in PBS) was added to
each well, and the plates were incubated for another 2 h at
37 °C. The culture medium was then replaced with 100 μl
of DMSO; diformazan formation was determined by
measuring absorption at 570 nm with a microplate reader
Tecan Infinite M200 Pro (Männedorf, Switzerland).
Animals
The study was conducted on white male rats of the
“Wistar” line weighing 170 ± 5 g. The animals were kept
under standard conditions in the vivarium of the ESC
“Institute of Biology and Medicine,” Taras Shevchenko
National University of Kyiv. Animals had free access to
food and water. All experiments were conducted in ac-
cordance with the international principles of the Euro-
pean Convention for protection of vertebrate animals
under a control of the Bio-Ethics Committee of the
abovementioned institution.
Estimation of Erythrocytes Hemolysis
Erythrocytes were obtained from heparinized blood of
the “Wistar” line rat and diluted in 0.85% NaCl solution
to 0.700 o.u. at 630 nm on the Scinco spectrophotom-
eter (Germany). Hemolysis of erythrocytes was caused
by 0.001 N HCl. The kinetics of hemolysis was measured
spectrophotometrically (λ = 630 nm) every 10 s during
2 min. The percentage of hemolysed erythrocytes was
calculated as presented in [20]. Erythrocytes were incu-
bated in 0.85% NaCl solution with C60 fullerene (16 μM)
or HL (2.5 and 10 μM) separately and together during
1 h. Erythrocytes without the addition of HL or C60 ful-
lerene were received as 100% (control sample contained
0.05 M DMSO).
In Silico Study
The double-helix DNA molecule was used as a template
from PDB (Protein Data Bank) base. The interaction of
DNA molecule with HL separately and in combination
with C60 fullerene has been studied. We took into con-
sideration the following structures of DNA molecule:
2MIW (CCATCGCTACC - intercalation of compound
into a small groove of DNA helix), 1XRW (CCTCGTCC
- intercalation of compound into a small groove of DNA
helix), and 2M2C (GCGCATGCTACGCG - binding of
compound with large and small grooves of DNA helix).
We applied the algorithm of systematical docking
(SDOCK+), built-in the QXP package (this method dem-
onstrates all possible conformations of the studied struc-
tures with the minimal value of Root mean square
deviation (RMSD)) [21]. We generated 300 potentially
possible complexes with DNA, the ten best of which
were selected for the next stage, using a scoring func-
tion, built-in the QXP package [22].
The interactions of the DNA molecule with HL separ-
ately and in combination with the C60 fullerene were
characterized by the following parameters: (1) the num-
ber of hydrogen bonds, (2) the area of contacting sur-
faces of DNA and corresponding structure, (3) the
distance between the DNA and docked structure, and
(4) the total energy of the binding structure.
To assess the stability of the complexes of chemical
compound with C60 fullerene, we conducted the short
molecular dynamics (MD, 100 ps) using Gromacs soft-
ware tool [23] according to a Nosé-Poincaré-Anderson
algorithm (NPA) [24, 25] based on OPLS-AA force field
[26, 27].
The calculations were performed on the following pa-
rameters: temperature (in Kelvin) - 300; pressure (in kilo-
pascal) - 100; binding involving the hydrogen atom or
ligand was limited by the algorithm [25].
Statistical Analysis
The data were represented as mean ± SD of more than
four independent experiments. Mean (M) and standard
deviation (SD) were calculated for each group. Statistical
analysis was performed using two-way ANOVA followed
by post Bonferroni tests. A value of p < 0.05 was consid-
ered statistically significant. Data processing and plotting
were performed by IBM PC using specialized applications
GraphPad Prism 7 (GraphPad Software Inc., USA).
Fig. 2 Scheme of solubility of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) in sodium salt
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Results and Discussions
In Silico Study
Interaction of HL with DNA
It was shown that HL could intercalate into DNA and
form stable complex when bound in a minor DNA groove
via AGC-GCTA nucleotides (Fig. 3a). In this case, the
stacking interaction between the nitrogenous base of A
nucleotide and HL phenyl group as well as electrostatic
interaction between CCl3 group and C nucleotide was
formed. After MD simulation, the RMSD values for DNA
double helix and HL were found to be 3.3 and 1.62 Å,
respectively. Nucleotide environment of HL (GCA-CTA)
was partly changed and stacking interaction was lost,
while a hydrogen bond was formed between G nucleotide
and CO group of HL.
Binding of HL with a major DNA groove occurred via
TCG-AT nucleotides (Fig. 3b). In this case, a hydrogen
bond between the CO group of HL and nitrogenous
base of A nucleotide was formed and stacking inter-
action between both HL phenyls and nitrogenous bases
of C and G nucleotides occurred. Besides, a probability
of electrostatic bond between HL CCl3 group and nitro-
genous bases of AT nucleotides appeared.
After MD simulation, no changes in the nucleotide en-
vironment of HL were detected. The RMSD values for
DNA and HL were 2.77 and 1.58 Å, respectively. Due to
it the stacking interaction between C nucleotide and
phenyl group disappeared.
In the case of HL intercalation into DNA, its environ-
ment consisted of CG-CG nucleotides (Fig. 3c). The
stacking interaction with CG nucleotides appeared: one
phenyl group was clamped between the nitrogenous
bases and the other formed a stacking interaction with
C nucleotide.
After MD simulation, the RMSD values for DNA
double-helix and HL were 1.71 and 1.89 Å, respectively.
The nucleotide environment of HL was not changed.
One of the phenyl group formed a ion-π interaction with
the nitrogenous base of G nucleotide, which appeared to
be shifted by 1.12 Å.
The obtained energy parameters testified that the en-
ergy of steric clashes between DNA and HL as well as
within HL itself was insignificant (Table 1).
We have done the comparative analysis of energy
parameters of HL binding with minor and major DNA
grooves or its intercalation into minor DNA groove.
Bump values were shown to be 6.2 kJ/mol in the case of
HL intercalation into DNA and 2.5 kJ/mol in the case of
its binding with minor and major DNA grooves (Table 1).
Int values were 8.7 kJ/mol in the case of HL intercalation
into DNA, 6.3 kJ/mol in the case of its binding with a
major DNA groove, and 3.6 kJ/mol in the case of its
binding with a minor DNA groove. These data showed
that HL binding with a minor groove of DNA was the
most stable.
Combined Interaction of HL and C60 Fullerene with DNA
Previously with the use of computer simulation, we have
demonstrated that C60 molecule could interact with
DNA and form a stable C60+DNA complex when bind-
ing with DNA minor groove [15]. As it is shown in Fig. 4,
C60 fullerene could also form ion-π bonds with CCl3
groups of HL molecule.
We have used two versions of molecular modeling of
HL, C60 fullerene and DNA interaction, which were pro-
posed in [16] and proved to be useful for interpretation
of MD simulation results. We have used 1XRW PDB
structure of DNA molecule in the version, when initially
HL and then C60 molecule intercalate into DNA (HL
+C60) and 2MIW PDB structure of DNA molecule - in
the version, when initially C60 molecule and then HL
intercalate into DNA(C60+HL).
The binding with a minor DNA groove in the case of
HL+C60 version occurred via GCTA-GCAT nucleotides
(Fig. 4a). Phenyl groups filled a minor groove and
entered into stacking interactions: one group with C60
Fig. 3 Interaction of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) with DNA molecule: a, b binding with minor and major grooves; c intercalation
into a minor groove. The used DNA structure from PDB database: a, b—2M2C and c—1XRW
Grebinyk et al. Nanoscale Research Letters  (2018) 13:81 Page 4 of 9
fullerene and the other one with the nitrogenous base of
G nucleotide. The electrostatic interactions arose be-
tween CCl3 group of HL and both the nitrogenous base
of G nucleotide and C60 fullerene.
According to MD simulation results, a DNA double
helix in this case was characterized by considerable mo-
bility (RMSD value is 3.08 Å), RMSD value for HL was
2.04 Å, while C60 fullerene remained virtually immov-
able. As a result, the nucleotide environment of HL+C60
structure was changed by TGC-GCATG. Besides, a
hydrogen bond between amino group of HL and DNA
and stacking interactions between the nucleotides of
nitrogenous GC bases and C60 fullerene appeared.
The binding of HL+C60 with a major DNA groove
occurred via C-ATCC nucleotides (Fig. 4b). Hydrogen
bonds were formed between HL CO group and the
nitrogenous base of A nucleotide. Phenyl groups filled a
major DNA groove and entered into stacking interaction
with C60 fullerene.
According to MD simulation results, the nucleotide en-
vironment of HL+C60 structure was not changed: the
values of RMSD for DNA and HL were 3.14 and 2.24 Å,
respectively, C60 fullerene remained virtually immovable.
In this case, all interactions between HL and C60 fullerene
disappeared and HL sterically interacted only with DNA.
It is supposed that as a result C60 fullerene as well as HL
would be pushed out from the major DNA groove.
When HL+C60 were intercalated into a minor DNA
groove (Fig. 4c), the binding with CGT-GAG nucleotides
occurred. C60 fullerene occurred to be built into a minor
DNA groove and to interact with it sterically. HL phenyl
groups formed stacking interactions with the nitrogen-
ous bases of CG-CG nucleotides. According to MD
simulation, the values of RMSD for DNA and HL were
2.29 and 2.13 Å, respectively, C60 fullerene remained
virtually immovable, and CC13 group of HL entered into
electrostatic interaction with the nitrogenous base of
G nucleotide.
In the case of C60+HL version, the binding with a
minor DNA groove (Fig. 4d) occurred via CGC-GCC
nucleotides. One of the HL phenyl groups formed a
stacking with C60 fullerene and the other with G nucleo-
tide. The CC13 group of HL appeared to form electro-
static bond with the nitrogenous base of C nucleotide.
According to MD analysis, the values of RMSD for DNA
and HL in this case were 2.35 and 2.75 Å, respectively,
C60 fullerene stayed immovable, and the nucleotide
environment of C60+HL structure was changed by
CGCT-GC. In addition, the C60 molecule penetrated
deeper into DNA and formed a stacking interaction with
the nitrogen base of C nucleotide.
According to the calculated energy parameters, the
complex formed in the case of C60+HL intercalation
into a minor DNA groove was the most rigid (the
Bump value 20.0 kJ/mol) (Table 1). In contrast in the
case of HL+C60 interaction with DNA, this parameter
was only 6.2 kJ/mol when HL+C60 was intercalated into
a minor DNA groove, 7.8 kJ/mol when it was bound
with a minor DNA groove, and 8.8 kJ/mol when it was
bound with a major DNA groove. Besides, the energy
Table 1 Energy parameters (kJ/mol) of diphenyl-N-(trichloroacetyl)-
amidophosphate (HL) interaction alone and in combination with
C60 fullerene with DNA double-helix
Structure The energy parameters
FreE Cntc Hbnd Bump Int
Binding with a major DNA groove
HL − 6.6 − 45.1 − 2.0 2.5 6.3
HL+С60 − 23.1 − 75.7 − 2.3 8.8 5.0
Binding with a minor DNA groove
HL − 13.1 − 56.8 − 1.8 2.5 3.6
HL+С60 − 23.3 − 84.7 0.0 7.8 6.8
Intercalation into a minor DNA groove
HL − 8.0 − 62.2 − 1.0 6.2 8.7
HL+С60 − 8.0 − 62.2 − 1.0 6.2 8.7
С60+HL − 23.5 − 100 0.0 20.0 5.2
FreE the total energy of compounds binding with DNA; Cntc the contact
energy of compounds interaction with DNA; Hbnd the energy of hydrogen
bonds; Bump the energy of steric clashes between DNA and build-in
compounds; Int the energy of steric clashes between the atoms of
build-in compounds
Fig. 4 Combined interaction of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) and C60 fullerene with DNA (HL+C60 or C60+HL versions): a, b
binding with minor and major grooves, c, d intercalation into minor and major grooves. The used DNA structures of the PDB database: a, b—2M2C,
c—1XRW, and d—2MIW
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parameters showed that formation of strong hydrogen
bonds inside HL+C60+DNA complex was possible only
in the case of binding with a major groove of DNA,
when the value of Hbnd was − 2.3 kJ/mol, in other
types of interaction it was equal zero or − 1.0 kJ/mol
(Table 1). Moreover, according to MD results in this
case both C60 fullerene and HL appeared to be displaced
from a major DNA groove.
Therefore, C60+HL binding with a minor DNA groove
is suggested to be the most probable version of C60
fullerene, HL, and DNA combined interaction.
In vitro Study of HL Biological Effects
CCRF-CЕM Cells Viability
In in vitro experiments, the long-term influence of
diphenyl-N(trichloroacetyl)-amidophosphate (HL) in the
range 2.5–10 μM on the viability of human leukemic
CCRF-CЕM cells was estimated by MTT test. Cells were
incubated for 24, 48, and 72 h in RPMI 1640 medium
with either 16 μM C60 fullerene or HL alone or their
combination. Viability of cells incubated without C60 or
HL was considered to be 100%.
At 24 h of incubation, no effect of HL on CCRF-CЕM
cells viability was observed (Fig. 5). Still at more pro-
longed incubation, the cytotoxic activity of HL in 5 and
10 μM concentration became obvious, cell viability at
48 h was inhibited by 25 and 33%, respectively, and con-
tinued to fall at 72 h.
It should be noted that 50% decrease of CCRF-CЕM
cells viability (IC50) was detected at 72 h under the action
of HL in 10 μM concentration (Fig. 5). Recently, we have
shown that another CAPh representative dimorfolido-N-
trichloracetylphosphorylamid caused 50% decrease of
CCRF-CЕM cells viability at 72 h in concentration 1 mM
[16]. The comparative analysis of these data demonstrates
that introduction of phenoxy instead of morfolido groups
into the structure of CAPh derivative allowed to decrease
by two orders its effective toxic concentration against
leukemic cells. We assume that conformational flexibility
of –P(O)(OC6H5) core ensured more effective interaction
of this compound with DNA.
No influence of C60 fullerene used alone on cell viability
during incubation period was detected (data not pre-
sented). At the same time, the results shown on Fig. 6
demonstrate that C60 fullerene intensified HL cytotoxic
activity against CCRF-CЕM cells. Under combined action
of C60 fullerene and HL, 50% decrease of cell viability was
observed at lower HL concentration (5 μM) and at earlier
period (48 h) of incubation than under the action of HL
by itself. Moreover at 72 h of combined action of C60
fullerene and HL, the cytotoxic effect of HL was detected
in a low 2.5 μM concentration at which HL by itself had
no influence on cell viability (Fig. 6).
Thus, C60 fullerene was shown to potentiate cytotoxic
effects of HL and to increase significantly leukemic cells
sensitivity to its action in a low concentration. Taking
into account that C60 fullerene is able to accumulate in-
side leukemic cells over 24 h [28] and to localize in
intracellular compartments [29–31], particularly in the
nucleus [32, 33], its interaction with nuclear DNA of
actively proliferated cancer cells should not be excluded.
So the data obtained in vitro are in accordance with
the results of in silico study and demonstrate that initial
binding of C60 molecule and then of HL with minor
DNA groove with formation of a stable complex could
be one of the possible reasons of their synergistic inhib-
ition of CCRF-CЕM cells proliferation.
Erythrocytes Resistance to Hemolysis
On estimation of anticancer potential of HL and C60 ful-
lerene combination, it is important to take into account
its possible effects on nonmalignant cells, in particular
on blood cells.
Fig. 5 Viability of CCRF-CEM cells incubated with diphenyl-N-(trichloroacetyl)-amidophosphate (HL) in different concentrations. (M ±m, n = 8); *p
< 0.05 compared to control cells
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Study of erythrocytes resistance to acidic hemolysis
allows to elucidate the influence of pharmacological
agent at the membrane level. Dynamics of hemolysis
reflects the dynamics of erythrocyte plasma membrane
disruption and hence the stability of its structural
organization. In Fig. 7, the dependence of the percentage
of hemolysis erythrocytes were incubated for 1 h in NaCl
solution without additions (control) and with either HL or
C60 fullerene alone or in combination. No influence of
16 μM C60 fullerene on erythrocytes hemolysis was
detected (not shown). HL in 2.5 μM concentration alone
or in combination with C60 affected erythrocytes resist-
ance to hemolysis (Fig. 7). Meanwhile, under the action of
HL in 10 μM concentration acceleration of hemolysis with
maximum at 20 s was detected. Combined action of
10 μM HL and C60 fullerene was followed by further
hemolysis intensification with 60% of hemolysed erythro-
cytes at 20 s.
The data obtained showed that application of C60
fullerene in combination with 2.5 μM HL had no harm-
ful effect on structural stability of blood erythrocytes
membrane and at the same time allow to increase
significantly cytotoxic activity of HL in this low concen-
tration against leukemic cells. Despite the synergetic
cytotoxic effect of C60 fullerene and HL in 10 μM con-
centration against leukemic cells, the application of their
combination appeared to be limited by intensification of
hemolytic effect.
Finally, in the context of the above in vitro study, it is
important to emphasize that a water/solid interface have
confined water which also can affect both the transport,
thermodynamic properties of nanostructures [34, 35],
and their interaction with cell membranes [36].
There are literature data on the intracellular localization
of carbacylamidophosphates derivatives, in particular,
penetration of phosphoramidates into the cells. Thus,
Fig. 6 Viability of CCRF-CEM cells incubated with diphenyl-N-(trichloroacetyl)-amidophosphate (HL) alone or in combination with 16 μM C60
fullerene. (M ±m, n = 8); *p < 0.05 compared to control cells; #p < 0.05 compared to HL
Fig. 7 Erythrocytes resistance to hemolysis in the presence of diphenyl-N-(trichloroacetyl)-amidophosphate (HL) separately and in combination with
16 μM C60 fullerene. (M±m, n = 8)
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phosphoramidate derivatives can penetrate throw the
membrane of MDA-231 breast cancer and lung cancer
(H460, H383, and H2009) cell lines [37]. Nitrobenzyl
phosphoramide mustards were shown to permeate across
cell membranes and to be localized in mitochondria of
NTR+ mammalian cells [10]. It is not excluded that C60
fullerene, which is able to penetrate the membrane of the
cancer cell due to passive diffusion or endocytosis [28, 30,
32] with accumulation in the nucleus and mitochondria
[30, 32, 33], could be a transporter of small antitumor
molecules [38–40].
Conclusions
A new representative of carbacylamidophosphates deriva-
tives which have two phenoxy substituens near phosphoryl
group diphenyl-N-(trichloroacetyl)-amidophosphate (HL)
was synthesized and tested as a cytotoxic agent itself and in
combination with C60 fullerene. According to molecular
simulation results, when C60 fullerene and then HL were
bound with a minor DNA groove, a rigid complex was
formed stabilized by stacking interactions of HL phenyl
groups with C60 fullerene and DNA G nucleotide, as well
as by interactions of HL CCl3 group by ion-π bonds
with C60 molecule and by electrostatic bonds with
DNA G nucleotide.
With the use of MTT test, we have shown cytotoxic
activity of HL against human leukemic CCRF-CM cells
with IC50 value detected at 10 μM concentration at 72 h
of cells treatment. The cytotoxic effect of HL was facili-
tated by C60 fullerene. Under combined action of 16 μM
C60 fullerene and HL, the value of IC50 was detected at
lower 5 μM HL concentration and at earlier 48 h period
of incubation and besides the cytotoxic effect of HL was
observed at a low 2.5 μM concentration at which HL by
itself had no influence on cell viability.
Previously, we have shown a significant toxic effect of
dimorfolido-N-trichloroacetylphosphoramide against hu-
man leukemic cells of different origin, but its effective
concentration was high and no enhancement of toxicity
after combined action with C60 fullerene was observed
[16]. We assume that introduction of flexible of –
P(O)(OC6H5) groups instead of morfolido groups into
CAPh derivative contributed to lowering of its toxic con-
centration against human leukemic cells ensuring its
effective interaction with C60 molecule and DNA. Binding
of C60 fullerene and HL with minor DNA groove with
formation of a stable complex is assumed to be one of the
possible reasons of their synergistic inhibition of CCRF-
CЕM cells proliferation.
We have revealed that application of C60 fullerene in
combination with 2.5 μM HL had no harmful effect on
structural stability of blood erythrocytes membrane, while
combination of C60 fullerene with 10 μM HL appeared to
be limited by intensification of hemolytic effect.
Thus, C60 fullerene was shown to potentiate cytotoxic
effect of HL and to increase significantly human
leukemic cells sensitivity to its action in a low concen-
tration. A combination of C60 fullerene with HL in a low
concentration 2.5 μM may be promising for further bio-
medical studies.
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